In human atopic disease a beneficial response to immunotherapy may be associated with humeral changes in serum IgE and subclass IgG. The aim of this study was to investigate the humeral response to allergen‐specific immunotherapy (ASIT) in dogs with atopic dermatitis. Twelve dogs with clinical signs consistent with atopic dermatitis and positive intradermal test reactions to house dust mite antigens (Greer Laboratories, Lenoir NC, USA) were studied. The clinical response to ASIT (Greer) was evaluated when blood samples were collected at 0, 2 and 4 weeks; and at 3, 6 and 12 months after starting ASIT. The ASIT was administered for a minimum of 9 months. The serum concentration of total and subclass IgG antibodies was measured against Dermatophagoides farinae and Dermatophagoides pteronyssinus antigens (Greer) by ELISA using polyclonal and monoclonal antidog IgG reagents, respectively. Serum IgE was measured using a Fc‐epsilon R1 receptor alpha chain‐based ELISA. The data were analysed using a multilevel model in MLwiN software (Institute of Education, University of London, UK). Antibody concentrations of IgE and total IgG increased during the period of administration of ASIT and decreased after ASIT was stopped. There was no obvious pattern in subclass‐IgG concentrations during ASIT. Response to ASIT was excellent (four dogs), equivocal (three dogs) or poor (five dogs). During ASIT a poor or equivocal response was associated with a statistically significant increase in IgE to D. pteronyssinus antigen compared with the excellent responders. This relationship was present to a lesser extent with IgE to D. farinae and total IgG to both antigens. This study was supported, in part, by the RCVS Alison Alston Canine Award and by Heska Corporation.
Read full abstract